Rapid Micro Biosystems (RPID) Cash & Equivalents (2020 - 2026)
Rapid Micro Biosystems (RPID) reported Cash & Equivalents of $300000.0 for Q1 2026, up 200.0% on a YoY basis from $100000.0 in Q1 2025, and up 200.0% sequentially from $100000.0 in Q4 2025.
Rapid Micro Biosystems (RPID) Cash & Equivalents (2020 - 2026) Analysis & Trends
Rapid Micro Biosystems (RPID) has 7 years of Cash & Equivalents data on file, last reported at $300000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash & Equivalents rose 200.0% year-over-year to $300000.0; the trailing twelve-month figure through Mar 2026 stood at $300000.0 (up 200.0% YoY), and the FY2025 full-year result was $100000.0, down 99.41% from the prior year.
- Cash & Equivalents advanced to $300000.0 in Q1 2026, from $100000.0 in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $62.5 million in Q1 2022 to a low of $100000.0 in Q4 2023.
- A 5-year average of $14.1 million and a median of $300000.0 in 2023 frame the typical range for Cash & Equivalents.
- Across the five-year window, Cash & Equivalents sank 99.6% in 2023 and jumped 18233.0% in 2025, its largest moves.
- Tracing RPID's Cash & Equivalents over 5 years: stood at $200000.0 in 2022, then tumbled by 50.0% to $100000.0 in 2023, then soared by 16811.0% to $16.9 million in 2024, then plunged by 99.41% to $100000.0 in 2025, then surged by 200.0% to $300000.0 in 2026.
- Business Quant data shows RPID's Cash & Equivalents at $300000.0 in Q1 2026, $100000.0 in Q4 2025, and $18.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 6.80 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 2.45 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.12 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.03 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 2.29 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 557.00 Mn |
| 10 | Rapid Micro Biosystems | 90.41 Mn | 80.98 Mn | 371,000.00 | 300,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 300,000.00 |
| Dec 31, 2025 | 100,000.00 |
| Sep 30, 2025 | 18.95 Mn |
| Jun 30, 2025 | 18.33 Mn |
| Mar 31, 2025 | 100,000.00 |
| Dec 31, 2024 | 16.91 Mn |
| Sep 30, 2024 | 22.04 Mn |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 100,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 200,000.00 |
| Mar 31, 2023 | 24.41 Mn |
| Dec 31, 2022 | 200,000.00 |
| Sep 30, 2022 | 25.83 Mn |
| Jun 30, 2022 | 49.72 Mn |
| Mar 31, 2022 | 62.50 Mn |
| Dec 31, 2021 | 300,000.00 |
| Sep 30, 2021 | 219.59 Mn |
| Jun 30, 2021 | 100.05 Mn |